Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Lett. 2013 Nov 1;340(2):161-70. doi: 10.1016/j.canlet.2012.11.004. Epub 2012 Nov 23.

Genomic sequencing in cancer.

Author information

1
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mtuna9@gmail.com.

Abstract

Genomic sequencing has provided critical insights into the etiology of both simple and complex diseases. The enormous reductions in cost for whole genome sequencing have allowed this technology to gain increasing use. Whole genome analysis has impacted research of complex diseases including cancer by allowing the systematic analysis of entire genomes in a single experiment, thereby facilitating the discovery of somatic and germline mutations, and identification of the insertions, deletions, and structural rearrangements, including translocations and inversions, in novel disease genes. Whole-genome sequencing can be used to provide the most comprehensive characterization of the cancer genome, the complexity of which we are only beginning to understand. Hence in this review, we focus on whole-genome sequencing in cancer.

KEYWORDS:

Cancer; Mutations; Structural rearrangements; Whole-genome sequencing

PMID:
23178448
PMCID:
PMC3622788
DOI:
10.1016/j.canlet.2012.11.004
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center